AURA
Price
$10.65
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
118 days until earnings call
OBIO
Price
$5.66
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
Ad is loading...

AURA vs OBIO

Header iconAURA vs OBIO Comparison
Open Charts AURA vs OBIOBanner chart's image
Aura Biosciences
Price$10.65
Change-$0.00 (-0.00%)
Volume$177.02K
CapitalizationN/A
Orchestra BioMed Holdings
Price$5.66
Change-$0.00 (-0.00%)
Volume$73.59K
CapitalizationN/A
AURA vs OBIO Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AURA vs. OBIO commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Sell and OBIO is a StrongSell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (AURA: $10.33 vs. OBIO: $5.66)
Brand notoriety: AURA and OBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 62% vs. OBIO: 121%
Market capitalization -- AURA: $512.43M vs. OBIO: $230.35M
AURA [@Biotechnology] is valued at $512.43M. OBIO’s [@Biotechnology] market capitalization is $230.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileOBIO’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • OBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than OBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 2 TA indicator(s) are bullish while OBIO’s TA Score has 5 bullish TA indicator(s).

  • AURA’s TA Score: 2 bullish, 6 bearish.
  • OBIO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, OBIO is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а -6.09% price change this week, while OBIO (@Biotechnology) price change was -9.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

AURA is expected to report earnings on Mar 12, 2025.

OBIO is expected to report earnings on Jan 25, 2023.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($512M) has a higher market cap than OBIO($230M). AURA YTD gains are higher at: 16.591 vs. OBIO (-38.007). OBIO has higher annual earnings (EBITDA): -58M vs. AURA (-89.06M). AURA has more cash in the bank: 187M vs. OBIO (65.2M). OBIO has less debt than AURA: OBIO (1.45M) vs AURA (19M). OBIO has higher revenues than AURA: OBIO (2.08M) vs AURA (0).
AURAOBIOAURA / OBIO
Capitalization512M230M223%
EBITDA-89.06M-58M154%
Gain YTD16.591-38.007-44%
P/E RatioN/AN/A-
Revenue02.08M-
Total Cash187M65.2M287%
Total Debt19M1.45M1,309%
TECHNICAL ANALYSIS
Technical Analysis
AURAOBIO
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
64%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
43%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 2 days ago
40%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 2 days ago
45%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 8 days ago
55%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 2 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
54%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
59%
View a ticker or compare two or three
Ad is loading...
AURA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIAOX49.820.08
+0.16%
Capital Advisors Growth Investor
VALIX12.94N/A
N/A
Value Line Capital Appreciation Investor
EAMAX16.31N/A
N/A
Lord Abbett Emerging Markets Equity A
VRMGX66.03-0.18
-0.27%
Virtus KAR Mid-Cap Growth R6
HILSX18.46-0.31
-1.65%
Hartford International Value R4

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with INSM. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then INSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
-7.67%
INSM - OBIO
36%
Loosely correlated
-2.37%
AURA - OBIO
35%
Loosely correlated
-4.40%
CALC - OBIO
33%
Poorly correlated
-0.29%
ALDX - OBIO
32%
Poorly correlated
-13.30%
OMER - OBIO
31%
Poorly correlated
-0.47%
More